Quarterly Updates29 May 2026, 06:52 pm
Bafna Pharma: FY26 Revenue ₹15,061.74 Lakhs
AI Summary
Bafna Pharmaceuticals Ltd's Board of Directors approved the audited financial results for the quarter and year ended March 31, 2026. The company reported revenue from operations of ₹15,061.74 lakhs for the year ended March 31, 2026, as compared to ₹14,559.92 lakhs in the previous year. The Board meeting commenced at 02:00 P.M and concluded at 04:00 P.M.
Key Highlights
- Bafna Pharma's FY26 revenue from operations is ₹15,061.74 lakhs.
- The Board approved the audited financial results for FY26.
- The audit report has an unmodified opinion from the Statutory Auditors.
- The Board meeting was held on May 29, 2026.
- Company received GST orders, appealing one demand and obtaining a stay on another.
Price Impact
More from BAFNAPHARM